Clinical Trials Directory

Trials / Completed

CompletedNCT02287792

18-FDG PET/CT Imaging and Clinical Decisions in Infective Endocarditis

Effect of 18-FDG PET/CT Imaging on Clinical Decision Making During the Acute Phase of Infective Endocarditis: a Multicenter Prospective Impact Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
150 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the impact of 18-FDG positron emission tomography (PET)/computed tomography (CT) imaging in the management of patients with suspected or proven IE in detecting cardiac valve damages and other extracardiac complications. The study will evaluate whether this procedure can change the clinical decisions (treatments, valve surgery, patients' overall care) and modify the diagnosis of IE.

Detailed description

Introduction: Infective endocarditis (IE) is a rare disease, often difficult to diagnose with a high mortality rate. Extra-cardiac manifestations, which can occur in 30 to 80% of cases, impact the outcome of the disease. Identifying these manifestations may help confirm an uncertain diagnosis and optimize patients' management. 18-FDG PET/CT imaging, widely used for cancer staging, may also detect hyper-metabolic areas related to extracardiac infectious complications of IE. It provides the opportunity to detect all extracardiac IE infectious complications through a single examination. The impact of 18-FDG PET/CT imaging on the management of IE has yet to be completely evaluated. Hypothesis: 18-FDG PET/CT implementation could result in both shortening of the initial diagnostic work-up of IE and therapeutic optimization. Primary objective: To evaluate the impact of 18-FDG PET/CT on patients' management, as measured by changes in IE therapeutic plans. Secondary objectives: * To evaluate the impact of 18-FDG PET/CT on the Duke-Li criteria for IE diagnosis * To evaluate the performance of 18-FDG PET/CT in detecting valve damages and extracardiac complications induced by the IE * To evaluate whether 18-FDG PET/CT may help identify the infection's portal of entry * To evaluate whether the detection of extracardiac complications by FDG PET/CT is associated with the 6-months survival rate * To identify clinical and biological determinants of extracardiac IE localizations and prognosis * To determine the inter-reader interpretation of the18-FDG PET/CT results and the reproducibility in preparation and acquisition method

Conditions

Interventions

TypeNameDescription
PROCEDURE18-FDG PET/CT scanWhole body 18-FDG PET/CT to assess cardiac and extracardiac complications in infective endocarditis

Timeline

Start date
2015-04-17
Primary completion
2016-04-01
Completion
2017-01-01
First posted
2014-11-11
Last updated
2025-08-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02287792. Inclusion in this directory is not an endorsement.